Docusign Declines 23% in 6 Months: Should You Buy the Stock Right Now?
Werte in diesem Artikel
Docusign, Inc.’s DOCU shares have significantly declined in the past six months. It has fallen 23.1% against the industry’s 1.1% growth and the Zacks S&P 500 composite’s 19.5% rally.6-Month Share Price Performance Image Source: Zacks Investment Research The recent performance paints a different picture, wherein DOCU shares have moved up 1.5% in the past month, signalling an end to the correction phase.The decline in DOCU shares over the past six months may appear highly appealing to investors, compelling them to initiate a buy. Let us analyze further to find out whether buying the stock now is a sound decision.Microsoft & Salesforce: DOCU’s Secret Sauce to IAMDocusign has collaborated with tech giants like Microsoft MSFT and Salesforce CRM to improve the integration capabilities of its Intelligent Agreement Management (IAM) platform. These partnerships are key to optimizing agreement workflows and generating AI-backed data that enhances user experience.DOCU’s decision to embed Microsoft 365 and Salesforce’s CRM suite provides swift agreement management within platforms used by enterprises on a regular basis. What this integration does best is the simplification of contract processes, boosting decision-making and creating a unified ecosystem where the collaboration between legal, sales and procurement teams is efficiently done.IAM has surpassed its status as just an e-signature solution and has become a comprehensive digital agreement hub. From drafting contracts within Microsoft Word to managing client pipelines in Salesforce, DOCU’s IAM ensures swift document movement via automated intelligent workflows. Partnering with these tech giants deepens customer reliance on Docusign’s offerings.DOCU’s partnership with Microsoft and Salesforce will play a pivotal role as businesses become more inclined toward modernizing agreement processes. We expect this collaborative approach to feed into enhancing DOCU’s user retention and boosting its competitive edge in the software-as-a-service landscape.DOCU: A Cheap Stock With Strong Capital ReturnsDocusign is priced at 17.44 times forward 12-month price-to-earnings, below the industry average of 34.09 times. It indicates that the market may be overlooking this stock’s potential, and there is a high chance that the stock price may increase if investors recognize its value. Hence, investors may find this stock appealing under the pretext that this undervalued stock may generate higher returns in the long run. Image Source: Zacks Investment Research On the return on capital front, DOCU’s return on equity is at 38% surpassing the industry’s 33.4%. It suggests that management is utilizing its capital effectively to generate profit. The fact that this metric beats the industry elevates the company's competitive edge. Image Source: Zacks Investment Research The ability to generate robust capital returns builds a strong case for the stock being undervalued, as it is a profitable and efficiently run company that the market is not valuing judiciously compared with its industry peers.DOCU’s Top & Bottom-Line Outlook Looks PromisingThe Zacks Consensus Estimate for DOCU’s fiscal 2026 revenues is pinned at $3.2 billion, hinting at 7.3% year-over-year growth. For fiscal 2027, the same is anticipated to grow 3.9% year over year. The consensus estimate for Docusign’s fiscal 2026 EPS stands at $3.69, indicating 3.9% year-over-year growth. For 2026, the estimate is set at 9.9% growth.Over the past 60 days, one EPS estimate for both fiscal 2026 and 2027 has been revised upward without any single downward adjustment. In the same period, the Zacks Consensus Estimate has moved up marginally.This enticing long-term growth trajectory solidifies DOCU’s position as a profitable company, hinting at its ability to generate long-term shareholder value.Buy Docusign NowWe recommend that investors buy this stock now despite its weakness over the past six months. The recent performance highlights that the stock has ended its correction phase, and we expect it to climb high in the long run.DOCU has discovered its strength in collaborating with tech giants to improve its IAM. In doing so, it has strengthened customer relationships and we expect this to provide a significant competitive edge.Our projection related to this stock's long-term growth is solidified by the fact that this fundamentally strong stock is trading at a discount and carries the potential to generate strong capital returns, waving a massive green flag for investors.DOCU currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.#1 Semiconductor Stock to Buy (Not NVDA)The incredible demand for data is fueling the market's next digital gold rush. As data centers continue to be built and constantly upgraded, the companies that provide the hardware for these behemoths will become the NVIDIAs of tomorrow.One under-the-radar chipmaker is uniquely positioned to take advantage of the next growth stage of this market. It specializes in semiconductor products that titans like NVIDIA don't build. It's just beginning to enter the spotlight, which is exactly where you want to be.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Microsoft Corporation (MSFT): Free Stock Analysis Report Salesforce Inc. (CRM): Free Stock Analysis Report Docusign Inc. (DOCU): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: DocuSign und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf DocuSign
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf DocuSign
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: Zacks
Nachrichten zu DocuSign Inc Registered Shs
Analysen zu DocuSign Inc Registered Shs
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.02.2019 | DocuSign Buy | Deutsche Bank AG | |
| 19.10.2018 | DocuSign Neutral | Wedbush Morgan Securities Inc. | |
| 22.05.2018 | DocuSign Hold | Deutsche Bank AG |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.02.2019 | DocuSign Buy | Deutsche Bank AG |
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.10.2018 | DocuSign Neutral | Wedbush Morgan Securities Inc. | |
| 22.05.2018 | DocuSign Hold | Deutsche Bank AG |
| Datum | Rating | Analyst | |
|---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv | |||
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für DocuSign Inc Registered Shs nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen